by Kazeem Olalekan MRPharmS The results of a recent YouGov survey conducted on behalf of the Royal Pharmaceutical Society gave me a great cause for concern. The first survey was completed from 10-15 February 2012 by 7,755 UK adults and the second survey from 17-22 February by
Read more →